logo

For the Inventor, By the Inventor

Westminster, CO, United States of America

Arca Biopharma, Inc.

USPTO Granted Patents = 14

% Expired Patents = 35.7


Forward Citations = 71

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Michael R Bristow (6 out of 19 patents)

silverMedal Arie Abo (5 out of 13 patents)

bronzeMedal Jonathan D Port (4 out of 4 patents)

4.  Wouter Korver (4 out of 7 patents)

5.  Christopher Dufton (2 out of 3 patents)

6.  Walter D Funk (2 out of 21 patents)

7.  Y Tom Tang (2 out of 92 patents)

8.  Bryan J Boyle (2 out of 10 patents)

9.  Radoje Drmanac (1 out of 134 patents)

10.  Makoto Kakitani (1 out of 4 patents)

11.  Kazuma Tomizuka (1 out of 29 patents)

12.  Takeshi Oshima (1 out of 2 patents)

13.  Minke Binners (1 out of 1 patent)

14.  Chiaoyun Kuo (1 out of 2 patents)

15.  Jian Rui Wang (1 out of 2 patents)


14 patents:

1. 11554107 - Methods and compositions involving bucindolol for the treatment of atrial fibrillation (2023-01-17),
2. 11452712 - Methods and compositions involving (S)-bucindolol (2022-09-27),
3. 10925856 - Methods and compositions involving bucindolol for the treatment of atrial fibrillation (2021-02-23),
4. 9763916 - Methods and compositions involving (S)-bucindolol (2017-09-19),
5. 9446023 - Methods and compositions involving (S)-bucindolol (2016-09-20),
6. 8993726 - Antibodies to NTB-A (2015-03-31),
7. 8946284 - Methods and compositions involving (S)-bucindolol (2015-02-03),
8. 8715941 - Antibodies to LRP6 (2014-05-06),
9. 8536310 - Antibodies to CLL-1 (2013-09-17),
10. 8193320 - Antibodies to NTB-A (2012-06-05),
11. 7981413 - Methods and compositions concerning antibodies that bind CD84-like polypeptides (2011-07-19),
12. 7951381 - Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor (2011-05-31),
13. 7847067 - Antibodies to NTB-A (2010-12-07),
14. 7674890 - Stem cell factor-like proteins and uses thereof (2010-03-09),
Company Overview
Arca Biopharma, Inc. is a biopharmaceutical company based in Westminster, Colorado, specializing in the development of innovative therapies for cardiovascular diseases. The company focuses on leveraging its proprietary genetic and biomarker technologies to create targeted treatments that address unmet medical needs. With a commitment to advancing personalized medicine, Arca Biopharma aims to improve patient outcomes through its research and development efforts in the field of cardiovascular health.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Arca Biopharma, Inc. USPTO Patent Assignee Logo
14 Patents

#11 in Westminster, CO

#458 in Colorado

#22,333 in US

#42,290 in the World

Westminster, CO (US)
Westminster, CO, United States of America

Arca Biopharma, Inc.

Forward Citations = 71

20 inventors:

goldMedal Michael R Bristow (6 out of 19 patents)

silverMedal Arie Abo (5 out of 13 patents)

bronzeMedal Jonathan D Port (4 out of 4 patents)

4.  Wouter Korver (4 out of 7 patents)

5.  Christopher Dufton (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arca Biopharma, Inc.. Retrieved from https://idiyas.com/company/arca-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…